NCT07038811 Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence
| NCT ID | NCT07038811 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Urgency Incontinence |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-06-12 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-06-12 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to evaluate the implementation and use of the Tät®II app for the treatment of urgency and mixed urinary incontinence in women over the age of 18 after contact with ordinary healthcare, as well as its effectiveness. The study aims to answer the following question: Is treatment via the app effective and feasible after primary care? Participants will use the app for 15 weeks to treat urgency and mixed urinary incontinence. They will answer online survey questions about their urinary incontinence before, after 15 weeks, and one year after treatment.
Eligibility Criteria
Inclusion Criteria: * Female gender * Age ≥18 years * Symptoms of urgency urinary incontinence or mixed urinary incontinence * Medical evaluation and documentation of urinary incontinence by ordinary doctor * Signed informed consent Exclusion Criteria: * Pregnancy * Childbirth in the last 6 months * Painful urges * Difficulties emptying the bladder * Blood in urine * Need of further investigation concerning the urinary incontinence, according to the clinical doctor
Contact & Investigator
Ina Asklund, MD, PhD
PRINCIPAL INVESTIGATOR
Umeå University
Frequently Asked Questions
Who can join the NCT07038811 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Urgency Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07038811 currently recruiting?
Yes, NCT07038811 is actively recruiting participants. Contact the research team at annelie.olofsson@umu.se for enrollment information.
Where is the NCT07038811 trial being conducted?
This trial is being conducted at Östersund, Sweden.
Who is sponsoring the NCT07038811 clinical trial?
NCT07038811 is sponsored by Umeå University. The principal investigator is Ina Asklund, MD, PhD at Umeå University. The trial plans to enroll 60 participants.